1. Home
  2. DALN vs PYXS Comparison

DALN vs PYXS Comparison

Compare DALN & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DALN
  • PYXS
  • Stock Information
  • Founded
  • DALN 1954
  • PYXS 2018
  • Country
  • DALN United States
  • PYXS United States
  • Employees
  • DALN N/A
  • PYXS N/A
  • Industry
  • DALN Newspapers/Magazines
  • PYXS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DALN Consumer Discretionary
  • PYXS Health Care
  • Exchange
  • DALN Nasdaq
  • PYXS Nasdaq
  • Market Cap
  • DALN 73.2M
  • PYXS 75.0M
  • IPO Year
  • DALN 2008
  • PYXS 2021
  • Fundamental
  • Price
  • DALN $14.94
  • PYXS $1.08
  • Analyst Decision
  • DALN
  • PYXS Strong Buy
  • Analyst Count
  • DALN 0
  • PYXS 5
  • Target Price
  • DALN N/A
  • PYXS $9.00
  • AVG Volume (30 Days)
  • DALN 379.5K
  • PYXS 363.2K
  • Earning Date
  • DALN 07-30-2025
  • PYXS 08-13-2025
  • Dividend Yield
  • DALN N/A
  • PYXS N/A
  • EPS Growth
  • DALN N/A
  • PYXS N/A
  • EPS
  • DALN N/A
  • PYXS N/A
  • Revenue
  • DALN $121,119,000.00
  • PYXS N/A
  • Revenue This Year
  • DALN N/A
  • PYXS N/A
  • Revenue Next Year
  • DALN N/A
  • PYXS N/A
  • P/E Ratio
  • DALN N/A
  • PYXS N/A
  • Revenue Growth
  • DALN N/A
  • PYXS N/A
  • 52 Week Low
  • DALN $3.66
  • PYXS $0.83
  • 52 Week High
  • DALN $16.10
  • PYXS $5.39
  • Technical
  • Relative Strength Index (RSI)
  • DALN 80.61
  • PYXS 41.90
  • Support Level
  • DALN $14.79
  • PYXS $1.09
  • Resistance Level
  • DALN $15.10
  • PYXS $1.38
  • Average True Range (ATR)
  • DALN 0.20
  • PYXS 0.08
  • MACD
  • DALN -0.23
  • PYXS -0.01
  • Stochastic Oscillator
  • DALN 53.04
  • PYXS 0.00

About DALN DallasNews Corporation Series A

DallasNews Corp is a local news and information publishing company. It operates The Dallas Morning News (dallasnews.com), Texas' newspaper. These operations generate revenue from advertising sales within the company's newspaper and digital platforms, subscriptions and retail sales of its newspaper, and commercial printing and distribution services predominantly related to national newspapers. In addition to traditional print and digital advertising, the company has a full-service agency, Medium Giant, offering businesses comprehensive, strategic, and creative marketing solutions. The company's two reportable segments are TDMN and Agency. Maximum revenue is derived from the TDMN segment, which comprises its traditional print business. The firm's customer base is concentrated in North Texas.

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

Share on Social Networks: